BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8579624)

  • 1. TMP-153, a novel ACAT inhibitor, lowers plasma cholesterol through its hepatic action in golden hamsters.
    Sugiyama Y; Odaka H; Itokawa S; Ishikawa E; Tomari Y; Ikeda H
    Atherosclerosis; 1995 Nov; 118(1):145-53. PubMed ID: 8579624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters.
    Sugiyama Y; Ishikawa E; Odaka H; Miki N; Tawada H; Ikeda H
    Atherosclerosis; 1995 Feb; 113(1):71-8. PubMed ID: 7755657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between bioavailability and hypocholesterolemic activity of YM17E, an inhibitor of ACAT, in cholesterol-fed rats.
    Uchida T; Aoyama K; Watanabe T; Higuchi S
    Atherosclerosis; 1998 Mar; 137(1):97-106. PubMed ID: 9568741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypocholesterolemic activity of a novel inhibitor of cholesterol absorption, SCH 48461.
    Salisbury BG; Davis HR; Burrier RE; Burnett DA; Bowkow G; Caplen MA; Clemmons AL; Compton DS; Hoos LM; McGregor DG
    Atherosclerosis; 1995 May; 115(1):45-63. PubMed ID: 7669087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological profile of SMP-797, a novel acyl-coenzyme a: cholesterol acyltransferase inhibitor with inducible effect on the expression of low-density lipoprotein receptor.
    Ioriya K; Kino K; Horisawa S; Nishimura T; Muraoka M; Noguchi T; Ohashi N
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):322-9. PubMed ID: 16495773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple mechanisms of hypocholesterolemic action of pactimibe, a novel acyl-coenzyme A:cholesterol acyltransferase inhibitor.
    Kitayama K; Koga T; Inaba T; Fujioka T
    Eur J Pharmacol; 2006 Aug; 543(1-3):123-32. PubMed ID: 16814766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
    Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
    Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of SMP-500, a novel acyl-coA:cholesterol acyltransferase inhibitor, on the cholesterol esterification and its hypocholesterolemic properties.
    Ioriya K; Noguchi T; Muraoka M; Fujita K; Shimizu H; Ohashi N
    Pharmacology; 2002 May; 65(1):18-25. PubMed ID: 11901297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism by which an ACAT inhibitor (CL 277,082) influences plasma lipoproteins in the rat.
    Balasubramaniam S; Simons LA; Chang S; Roach PD; Nestel PJ
    Atherosclerosis; 1990 May; 82(1-2):1-5. PubMed ID: 2360913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of a direct effect on hepatic acyl CoA: cholesterol acyl transferase (ACAT) activity by an orally administered enzyme inhibitor in the hamster.
    Burrier RE; Deren S; McGregor DG; Hoos LM; Smith AA; Davis HR
    Biochem Pharmacol; 1994 Apr; 47(9):1545-51. PubMed ID: 8185666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of SR-BI in hamsters treated with a novel ACAT inhibitor (F12511).
    Milliat F; Férézou J; Delhon A; Lutton C
    C R Acad Sci III; 2001 Mar; 324(3):229-34. PubMed ID: 11291309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological properties of a novel ACAT inhibitor (CP-113,818) in cholesterol-fed rats, hamsters, rabbits, and monkeys.
    Marzetta CA; Savoy YE; Freeman AM; Long CA; Pettini JL; Hagar RE; Inskeep PB; Davis K; Stucchi AF; Nicolosi RJ
    J Lipid Res; 1994 Oct; 35(10):1829-38. PubMed ID: 7852860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent pharmacologic activities of PD 132301-2 and CL 277,082, urea inhibitors of acyl-CoA:cholesterol acyltransferase.
    Krause BR; Black A; Bousley R; Essenburg A; Cornicelli J; Holmes A; Homan R; Kieft K; Sekerke C; Shaw-Hes MK
    J Pharmacol Exp Ther; 1993 Nov; 267(2):734-43. PubMed ID: 8246149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of LY295427, a low-density lipoprotein (LDL) receptor up-regulator, on LDL receptor gene transcription and cholesterol metabolism in normal and hypercholesterolemic hamsters.
    Bensch WR; Gadski RA; Bean JS; Beavers LS; Schmidt RJ; Perry DN; Murphy AT; McClure DB; Eacho PI; Breau AP; Archer RA; Kauffman RF
    J Pharmacol Exp Ther; 1999 Apr; 289(1):85-92. PubMed ID: 10086991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological profile of F 12511, (S)-2',3', 5'-trimethyl-4'-hydroxy-alpha-dodecylthioacetanilide a powerful and systemic acylcoenzyme A: cholesterol acyltransferase inhibitor.
    Junquero D; Oms P; Carilla-Durand E; Autin J; Tarayre J; Degryse A; Patoiseau J; Colpaert FC; Delhon A
    Biochem Pharmacol; 2001 Jan; 61(1):97-108. PubMed ID: 11137714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of SMP-500, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on serum cholesterol level and LDL cholesterol clearance in hamsters with induced hyperlipidemia.
    Ioriya K; Kino K; Sato YF; Ohashi N
    Pharmacology; 2002 Oct; 66(2):107-14. PubMed ID: 12207118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ACAT inhibitor, CI-1011 is effective in the prevention and regression of aortic fatty streak area in hamsters.
    Nicolosi RJ; Wilson TA; Krause BR
    Atherosclerosis; 1998 Mar; 137(1):77-85. PubMed ID: 9568739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesterol esterification is not essential for secretion of lipoprotein components by HepG2 cells.
    Graham A; Wood JL; Russell LJ
    Biochim Biophys Acta; 1996 Jul; 1302(1):46-54. PubMed ID: 8695654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CL 277,082: a novel inhibitor of ACAT-catalyzed cholesterol esterification and cholesterol absorption.
    Largis EE; Wang CH; DeVries VG; Schaffer SA
    J Lipid Res; 1989 May; 30(5):681-90. PubMed ID: 2760542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.